| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO | SVP, Interim CFO | SVP, Interim CFO
1 company
Borthwick Kathleen is a CFO at Passage BIO, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $30K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | PASG Passage Bio, Inc. | CFO | Sale+OE | 2,062 | $18.44 | $38,022.04 | -27.6% | -49.3% | - | |
| Feb 11, 2025 | PASG Passage Bio, Inc. | CFO | Sale+OE | 3,183 | $0.53 | $1,685.72 | -7.2% | -41.7% | -17.1% | |
| Feb 13, 2024 | PASG Passage Bio, Inc. | SVP, Interim CFO | Sale+OE | 1,470 | $0.97 | $1,425.90 | -4.9% | +49.5% | -47.5% | |
| Jan 2, 2024 | PASG Passage Bio, Inc. | SVP, Interim CFO | Sale+OE | 10,672 | $0.91 | $9,711.52 | -29.2% | +52.0% | -7.9% |